Albumin–globulin ratio is a predictive biomarker of antitumour effect of immune checkpoint inhibitors in cancer patients
AGR is a simple, inexpensive, and non-invasive biomarker with significant prognostic value in patients undergoing ICI therapy. These findings support its potential role in guiding clinical decision-making and optimizing patient selection for immunotherapy.
Authors
- Fujiang Xu (ORCID: https://orcid.org/0000-0002-7900-5319)
- Kaixiang He
- Yuhao Luo (ORCID: https://orcid.org/0000-0002-7489-5770)
- Xiang Li (ORCID: https://orcid.org/0009-0006-2707-4941)
Institutions
- Affiliated Hospital of Southwest Medical University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1080/07853890.2025.2591219
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00